About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Clinical Neuromuscular Disease
›
Top Articles
Journal of Clinical Neuromuscular Disease
Neurology
,
Clinical Neurology
1.1
(top 13%)
Impact Factor
1.2
(top 13%)
extended IF
29
(top 13%)
H-Index
190
authors
836
papers
5K
citations
1.2K
citing journals
3.2K
citing authors
Most Cited Articles of Journal of Clinical Neuromuscular Disease
Title
Year
Citations
Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy
2001
132
Treatment-refractory myasthenia gravis
2014
79
The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales
2010
75
Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis
2009
73
Metabolic myopathies: update 2009
2009
69
Low bone mineral density in spinal muscular atrophy
2008
58
Exertional rhabdomyolysis: a clinical review with a focus on genetic influences
2012
54
Morvan syndrome: a case report and review of the literature
2012
52
Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy
2008
50
Evaluation of patients with symptoms suggestive of chronic polyneuropathy
2001
46
Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review
2017
44
Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess
2014
43
The Charcot joint: a modern neurologic perspective
2011
43
Juvenile myasthenia gravis: a twenty-year experience
2013
39
Paraneoplastic Isaacs' syndrome: a case series and review of the literature
2012
38
On the concept of myasthenic crisis
2002
38
Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response
2011
37
Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005)
2009
36
Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report
2020
35
Neuromuscular disorders in critically ill patients: review and update
2011
35
Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis
1999
35
Primary lateral sclerosis: clinical and laboratory features in 25 patients
2005
34
Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study
2011
33
Survival probabilities of patients with childhood spinal muscle atrophy
2009
33
A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis
2008
33
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.